Clinical Trial Update: Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX [Phase 2]

View source ↗

Summary

Phase 2 liver transplantation trial comparing sequential therapy with tacrolimus plus an anti-IL-2 receptor monoclonal antibody and mycophenolate mofetil versus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• FK506 (Tacrolimus) (Tacrolimus)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Monoclonal anti-IL2R antibody

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Liver Transplantation | Phase 2 | Status: COMPLETED